![]() |
|
|
Vol. 281, Issue 2, 921-927, 1997
Pharmaceuticals Laboratory 2 (H.K.), Pharmaceuticals Laboratory 1 (M.S., S.Y., T.W., K.S.), and Pharmacokinetics and Drug Metabolism Laboratory (H.N.), Yokohama Research Center, Mitsubishi Chemical Corporation, 1000, Kamoshida-cho, Aoba-ku Yokohama 227, Japan
| |
Abstract |
|---|
|
|
|---|
We investigated the effects of a free radical scavenger, 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186), on infarct areas, neurological deficits and regional cerebral blood flow (rCBF), with use of a rat thrombotic distal middle cerebral artery (dMCA) occlusion model to elucidate its possible therapeutic effects on focal cerebral ischemia. In addition, we have attempted to measure 2-oxo-3-(phenylhydrazono)-butanoic acid (OPB), which is the major oxidation product of MCI-186, in the penumbral cortex of a thrombotic dMCA occlusion model. Postischemic treatment with MCI-186 (3 mg/kg) significantly (P < .05) decreased the size of the cerebral infarcts 1 day after dMCA occlusion. MCI-186 (3 mg/kg) significantly (P < .05) improved the neurological deficits 1 day after dMCA occlusion. On the contrary, MCI-186 had no effect on rCBF 1 day after dMCA occlusion. MCI-186 mainly reacted into OPB by peroxidation in rat brain homogenates. Furthermore, the increase in OPB content in the ischemic penumbral cortex tissue was confirmed after 90 min of MCI-186 perfusion. These results suggest that MCI-186 has a protective effect on brain ischemia by reacting with oxygen radicals and that oxygen radicals are closely related to postischemic brain injury.
| |
Introduction |
|---|
|
|
|---|
Although the mechanisms of
ischemic brain damage have not been clearly determined, accumulated
experimental evidence suggests that production of free radicals is
possibly one of the major factors involved (Flamm et al.,
1978
; Siesjo et al., 1989
; Siesjo, 1992
). Several reports
have demonstrated that free radicals generated during ischemia play an
important role in the development of neuronal damage (Chan, 1992
;
Kinouchi et al., 1991
; Kitagawa et al., 1990
; Cao
and Phillis, 1994
).
Free radical species of potential importance in cerebral ischemia
include superoxide and hydroxyl radicals. The hydroxyl radical is
highly reactive among oxygen radicals. Once excessive hydroxyl radicals
are released, lipid peroxidation, which causes changes in the fluidity
and permeability of membranes, is induced (Schmidley, 1990
). Recently,
oxygen radical formation was confirmed in the penumbral cortex during
middle cerebral artery occlusion by the use of salicylate hydroxylation
(Morimoto et al., 1996
; Ginsberg et al., 1994
).
MCI-186 is a potent scavenger of hydroxyl radicals inhibiting not only
hydroxyl radicals but iron-induced peroxidative injuries (Murota
et al., 1990
; Watanabe et al., 1988
).
Furthermore, MCI-186 has been reported to have protective effects in
both hemispheric embolization and transient cerebral ischemia in rats
(Abe et al., 1988
; Nishi et al., 1989
; Oishi
et al., 1989
; Watanabe et al., 1994a
,b
).
Recently, it has been proved that MCI-186 changes into OPB after the
reaction with peroxy radicals in vitro (fig.
1) (Yamamoto et al., 1996
). Thus, we are
particularly interested in evaluating the effects of MCI-186 on
ischemic brain damage and detecting this OPB in the penumbral area of
the ischemic brain to emphasize the involvement of the reaction with
radicals in its potent antiischemic effects.
|
In the present study, the effects of MCI-186 on infarct areas, neurological deficits and rCBF in a rat thrombotic dMCA occlusion model was investigated. In addition, we have measured the oxidation products of MCI-186 in the penumbral cortex of a thrombotic dMCA occlusion model.
| |
Materials and Methods |
|---|
|
|
|---|
Animal preparation.
Male Sprague-Dawley rats weighing 250 to
350 g were used. For the microdialysis study, the animals were
anesthetized by inhalation of 2% of halothane in 70% nitrous oxide
and 30% oxygen and spontaneous respiration. Body temperature was
maintained at 37.5°C with a heating pad (K-module Model K-20,
American Pharmaseal Company, Valencia, CA) during the operation. Head
temperature was monitored and maintained at 37.0°C throughout the
experiment by a warming lamp placed above the head. CCA occlusion was
performed according to the method of Chen et al. (1986)
. The
MCA thrombosis model in the rat was described previously (Umemura
et al., 1993
). A catheter for the administration of rose
bengal was placed in the femoral vein. The left CCA was occluded
permanently with a 3-0 suture. After the occlusion of the left CCA, the
scalp and temporalis muscle were folded over and a subtemporal
craniotomy was performed with a dental drill under an operating
microscope to open an elliptical bone window (4 mm in major axis).
Photoirradiation. The window was irradiated with green light; and the entire irradiated segment, including the Y-shaped juncture of the frontal and parietal branches of the left MCA, became thrombotically occluded. Photoirradiation with green light (wave length, 540 nm) was achieved by use of a xenon lamp (L4887: Hamamatsu Photonics, Hamamatsu, Japan) with a heat-absorbing filter and a green filter. The light source was a short-arc type, Super-Quiet xenon lamp. The xenon lamp was chosen for the high brightness and stable light intensity necessary for irradiating a small area. The light was prefiltered and concentrated by an elliptical reflector that had a special coating for efficient absorption of infrared and ultraviolet radiations. The remaining visible light was modified spectrally by filters to produce pure green light with a bandwidth of 80 nm, centered at 540 nm. Elimination of infrared and ultraviolet radiations was essential, because they can heat up and damage biological tissues. The irradiation was directed by an optic fiber 3 mm in diameter mounted on a micromanipulator. The head of the optic fiber was placed on the window in the skull base at a distance 2 mm above the vessel, and it provided an irradiation dose of 0.62 W/cm2. The local brain temperature in the brain was not modified by the light irradiation. Rose bengal (20 mg/kg, Wako, Osaka, Japan) was injected intravenously. The complete MCA photothrombotic occlusion was observed under a microscope approximately 4 min after i.v. injection of rose bengal. Photoirradiation was continued for a further 10 min. The drugs were administered i.v. 5 min and 35 min after dMCA occlusion. The photochemical reaction between rose bengal and the green light caused endothelial cell injury followed by platelet adhesion and the formation of a platelet-rich thrombus. The neck and head wounds were closed, the catheter was removed and the animal was returned to its home cage when fully awake. In the sham operation group, each animal's vessel was identified but was not occluded.
Behavioral testing.
For behavioral testing and histological
studies, four groups of rats were studied: sham-operated animals,
vehicle-administered controls and MCI-186-treated animals at doses of 1 and 3 mg/kg. Each group had 10 animals. According to the method of
Bederson et al. (1986)
, neurological deficits such as
hemiplegia were evaluated in a posture test 24 h after the
occlusion. This evaluation was carried out in a blind fashion, the
behavioral evaluations and experiments being performed by different
investigators.
Histological procedures.
After the neurological examination,
the brain was removed immediately and cut into six coronal slices (1 mm
in thickness) by a rat brain slicer (Zivic-Miller Lab., Inc., Allison
Park, PA). For determining the infarction area, each section was
stained with the TTC (Wako, Osaka, Japan) solution. Infarcted areas
were not stained by TTC (Isayama et al., 1991
). The size of
the infarcted area was measured by a computerized image analysis system
(Nexus, Tokyo, Japan). Infarct volumes were derived at the position
between slice 1 and slice 6 by means of sequentially numbered areas.
Measurement of rCBF.
Measurement of rCBF was determined by
the IAP quantitative autoradiographic technique described by Sakurada
et al. (1978)
. Under anesthesia with ether, cannulas were
implanted into the femoral artery and vein, and the animals were placed
in an apparatus for fixation 1 day after dMCA occlusion. Two hours or
more after recovery from anesthesia, 740 kBq of IAP (specific activity,
20 GBq/mmol, New England Nuclear Corp., Boston, MA) was infused i.v. over a period of 45 s, during which time repeated blood samples were taken from the femoral artery catheter. The blood samples were
collected in drops onto filter papers disks (1.5 cm square). At 45 s rats were decapitated, and the brain was rapidly removed from the
skull and frozen in powder dry ice. The radioactivity in the brain was
measured by autoradiography. The brains were cut into sections, 20 µm
in thickness, by means of a cryomicrotome (Bright 5030, UK) at
20°C. A series of five serial sections were prepared approximately
every 500 µm from 1.2 mm anterior to bregma, and numbered from the
front side. The autoradiographic sections were then attached to
radiographic film (IX150, Fuji Film, Tokyo, Japan), which was exposed
for 2 weeks, together with a set of standard film (RPA504L, Amersham,
Arlington Heights, IL). The filter paper disks containing the blood
samples were transferred to scintillation counter vials and suspended
in 10 ml of scintillator solution (ACS-II, Amersham) followed by
measurement of blood radioactivity in a liquid scintillation counter
(TRI-CARB, Packard Instrument Co., Rockville, MD).
|
Drug administration methods. MCI-186 was synthesized by Mitsubishi Chemical Corporation (Tokyo, Japan). MCI-186 was dissolved in 1 N NaOH and titrated to pH 7.4 with 1 N HCl to prepare concentrations of 10 and 30 mg/ml. Drugs used in this study were physiological saline (vehicle, 1 ml/kg) and MCI-186 (1 or 3 mg/ml/kg, bolus injection). The drugs were administered i.v. 5 min and 35 min after dMCA occlusion.
Preparation of rat brain homogenates. Five male Sprague-Dawley rats weighing 250 to 350 g were decapitated after transcardiac perfusion with 50 ml of saline at 100 mm Hg while under pentobarbital anesthesia. The cerebrum was removed and homogenized in 9 volumes of 67 mM phosphate buffer (pH 7.4) in an ice-cold bath. The homogenate was centrifuged at 900 × g for 10 min. The supernatant was incubated with 14.8 to 20.6 µM [14C]MCI-186 at 37°C for 30 min. Five separate experiments were carried out with use of five rats.
Measurement of [14C]MCI-186 and radical reaction
products.
To 500 µl of sample in a glass tube was added 200 µl
of 4
-methyl-MCI-186 acetonitrile solution (1 mg/ml) which was used for an antioxidant, 100 µl of MCI-186 acetonitrile solution (1 mg/ml) and
3.7 ml of acetonitrile. The tube was placed on a vortex mixer for 1 min. The supernatant and precipitation were separated by centrifugation
at 1600 × g for 5 min. The supernatant was evaporated to dryness in rotary evaporator at 50°C, the residue was dissolved in
400 µl of HPLC solvent A. The solution was filtered through a
millipore filter (0.45 µm), and 250 µl of aliquot was applied in
HPLC. To the precipitation in a glass tube was added 2 ml of 2 N NaOH.
The tube was heated at 90°C for 10 min in a water bath, and titrated
to pH 7.5 with 1 N HCl, which was then extracted with 10 ml of butanol
for 10 min and centrifuged at 1600 × g for 5 min. The
organic phase was evaporated to dryness in rotary evaporator at 50°C,
the residue was dissolved in 400 µl of HPLC solvent A. The solution
was filtered through a millipore filter (0.45 µm), and 250 to 300 µl of aliquot was injected in HPLC.
High performance liquid chromatography. The apparatus was composed of a pump (L-6200, Hitachi, Tokyo, Japan), an injector (7161, Rheodyne, Cotati, CA), a column oven (TCM, Waters Associates, Milford, MA), a radioactive detector (Ramona-5-LS, Raytest, Germany) a fraction collector (model 202, Gilson, Middleton, WI) and a UV detector (SPD-6A, Shimadzu, Kyoto, Japan). The analysis was done with an L-column ODS (4.6 mm internal diameter × 250 mm, Chemicals Inspection and Testing Institute, Tokyo, Japan). The column temperature was 50°C. The analysis required gradient elusion. The eluents were: Solvent A, methanol-100 mM phosphate buffer (pH 5.7) (30:70, v/v) with 5 mM TBA; solvent B, methanol-100 mM phosphate buffer (pH 5.7) (60:40, v/v) with 5 mM TBA. The gradient used was 3 min of 95% solvent A, linear programming during 17 min to 100% solvent B, 15 min of 100% solvent B, reequilibration to 95% solvent A. The flow rate was 1 ml/min, and the elute was monitored radioactivity and UV absorption at 254 nm.
Microdialysis study.
A craniectomy for microdialysis was
made above the left frontoparietal cortex with a dental drill. A small
incision was made in the dura and pia-arachnoid with a 27-gauge needle
to permit implantation of a microdialysis probe without a possible
compression injury to the cortex. A microdialysis probe (2-mm dialysis
membrane, CMA/11; Carnegie Medicin, Stockholm, Sweden) was
stereotaxically implanted in the left dorsolateral parietal cortex. We
positioned the microdialysis probe proximate to a motor area. The probe
was continuously perfused with Ringer's solution (147 mM NaCl, 4 mM KCl, 1.3 mM CaCl2) at a flow rate of 2 µl/min by means of
a microinfusion pump (CMA100; Carnegie Medicin, Stockholm, Sweden). The
perfusion fluid was switched to [14C]MCI-186 (9.1-11.3
mM) in Ringer's solution 10 min after dMCA occlusion. The MCI-186
perfusion was continued for a further 90 min. The perfusate sample was
collected. In the sham-operated group; MCI-186 was perfused by the same
method as in the dMCA occlusion group. After the
[14C]MCI-186 perfusion, the rats were decapitated. The
brains were quickly removed, and 400 µl of water, 200 µl of
4
-methyl-MCI-186 acetonitrile solution (1 mg/ml), 100 µl of MCI-186
acetonitrile solution (1 mg/ml) and 2.9 ml of acetonitrile were added
to the left cortex. The mixture was homogenized with a Polytoron
(Kinematica, Switzerland). The supernatant and precipitation were
separated by centrifugation at 1600 × g for 5 min.
Statistical analysis. Statistical analysis of the infarction size was conducted by analysis of variance, and paired comparisons with a control group were performed by Dunnett's test. Neurological deficits comparisons with a control group were analyzed by nonparametric Dunnett's test. The OPB levels were statistically analyzed by the student's t test. The statistical analysis was performed by Super ANOVA and Yukms. Data were expressed as mean ± S.E.
| |
Results |
|---|
|
|
|---|
The preliminary experiments revealed that MCI-186 did not exert any influence on the brain or body temperature during the early stage of the drug treatment, compared with the vehicle-treated control (data not shown).
Influence of MCI-186 on infarct volume, neurological deficits and
rCBF.
There were no areas of ischemia in the cerebral hemispheres
of the sham-operated animals. The infarction areas were predominantly located in the frontal and sensorimotor regions of the cortex. Figure
2 demonstrates a typical example of a cerebral
infarction in this study. Infarct volume in the high dose of MCI-186
was significantly (P < .05) reduced compared with the
vehicle-treated group (fig. 3).
|
|
|
|
Formation of the radical reaction products of MCI-186 in brain homogenates. [14C]MCI-186 was incubated with rat brain homogenates for 30 min at 37°C. Table 2 shows the extraction rate of radioactivity and the composition of extracted radioactivity on HPLC. The recovery ratio of radioactivity to acetonitrile/water supernatant from the preincubation sample and the reaction sample were about 100% and 60%, respectively. About 70% of radioactivity in precipitation from the reaction sample was extracted to butanol after alkaline hydrolysis. Figure 6a shows a typical chromatogram of standards of MCI-186 and OPB dissolved in HPLC solvent A. The peaks of MCI-186 and OPB can be separated. As shown in figure 6b, except for the peak of [14C]MCI-186, no peak was observed in a preincubation sample, which demonstrated that MCI-186 was not reacted during sample preparation. Figure 6c shows a chromatogram of a supernatant from the reaction sample. The compositions of MCI-186 and OPB were about 70% and 6%, respectively. As shown in figure 6d, the fraction of radioactivity was mostly OPB in the extract of the precipitation from the reaction sample. The composition of OPB was 90%, and MCI-186 was not detected. Figure 6e shows a typical chromatogram of the precipitation sample spiked with the standard of OPB, which was monitored by UV absorption. Retention time for OPB was shifted in every precipitation sample, so monitoring the retention time for OPB were carried out by spiked the standard of OPB.
|
|
Formation of the radical reaction products of MCI-186 in ischemic
penumbra.
After the perfusion of [14C]MCI-186 to the
ischemic penumbral region by the microdialysis method, the
radioactivity of the brain cortex was extracted to acetonitorile and
butanol and was analyzed by HPLC. The OPB were not detected in the
microdialysis perfusate taken from both the sham-operated and dMCA
occlusion cortex (data not shown). The recovery ratio of the
radioactivities to the supernatant from the rat
cortex/acetonitrile/water mixture were 87.1 ± 0.9%, 94.2 ± 1.4% in the sham-operated and dMCA occlusion group, respectively. The
fraction of radioactivity was mostly MCI-186. On the other hand, OPB
was detected mainly from the extract after alkaline hydrolysis of the
precipitation in both groups (fig. 7). The extraction ratio of radioactivity to butanol from the precipitation were 62.3 ± 3.3% and 53.9 ± 4.8% in the sham and dMCA occlusion group, respectively. Contents of OPB in the extraction was shown in table 3. The OPB significantly elevated throughout thrombotic
dMCA occlusion (P < .05).
|
|
| |
Discussion |
|---|
|
|
|---|
The thrombotic occlusion of dMCA was induced by the photochemical
reaction between rose bengal and green light, which causes endothelial
injury followed by platelet adhesion and formation of a platelet and
fibrin-rich thrombus without affecting dura mater (Umemura et
al., 1993
; Matsuno et al., 1993
). The infarction of
this model was observed mainly in the cortical area ipsilateral to the
occluded MCA 1 day after the thrombus formation. Chen et al.
(1986)
and Markgraf et al. (1993)
reported that the
occlusion of dMCA by electrocoagulation induced the infarction limited
to the cortex after MCA occlusion. The site of the infarction in our
model was similar to the site in these models.
The present results showed that MCI-186 improved both the neurological
deficits and the infarction area. This was supported by the observation
that appearance of neurological deficits in the posture test has a good
correlation with infarct area (Bederson et al., 1986
). On
the contrary, MCI-186 had no effect in rCBF 1 day after dMCA occlusion.
This suggests that it would be difficult for the histological outcome
to correlate with the changes in rCBF 1 day after dMCA occlusion. Hakim
et al. (1992)
have also reported that there is no
predictable correlation between the time-dependent changes affecting
rCBF and the histological changes 2 days after MCA occlusion. Recently,
it was demonstrated that the relationship between local cerebral
glucose utilization and rCBF was disturbed in the acute focal ischemic
penumbra and led to irreversible ischemic damage (Back et
al., 1995
). MCI-186 might affect the metabolism-flow uncoupling
during the first hours after dMCA occlusion. Further investigations in
acute stage are needed.
The cerebral ischemia causes the NO synthase induction of endothelium,
monocyte and macrophage. In the ischemic neurons, the excessive
activation of the N-methyl-D-aspartate receptor
also causes the Ca++-dependent stimulation of NO synthase
(Dawson et al., 1991
; Garthwaite, 1991
; Synder, 1992
). NO
rapidly reacts with superoxide in aqueous solution to form
peroxynitrite. Under physiological conditions, peroxynitrite is easily
photonated to form peroxynitrous acid. After photonation, peroxynitrous
acid is decomposed to the hydroxyl radical (Lipton et al.,
1993
). MCI-186 is thought to react with the hydroxyl radical which was
induced by NO. Therefore, MCI-186 might reduce the neuronal damage by
NO production during ischemia. On the other hand, it is not known that
MCI-186 might alter NO synthase and might react with NO itself. MCI-186
might not affect rCBF increase by NO.
Zaleska and Floyd (1985)
reported that there is hydroxyl
radical-dependent and iron-dependent lipid peroxidation in rat brain homogenates. Additionally, MCI-186 has been reported to prevent lipid
peroxidation in rat brain homogenates (Watanabe et al., 1994a
), and MCI-186 changes into OPB after the reaction with peroxy radicals (Yamamoto et al., 1996
). In the present study, we
demonstrated that OPB was isolated from the reaction mixture, including
rat brain homogenates and MCI-186. This finding suggests that MCI-186 reacts with free radicals in OPB inhibiting the lipid peroxidation in
rat homogenates and that OPB could also be isolated from rat brain
homogenates.
In the present study, OPB was increased in the cortical penumbra of the rat ischemic brain after 90 min of MCI-186 perfusion in this area. These findings demonstrate that MCI-186 can react with oxygen radical species in the penumbra area of the ischemic brain and therefore might show the protective effect on the ischemic brain damage.
Recently, Morimoto et al. (1996)
have reported that hydroxyl
radical formation was increased in the penumbral cortex during the MCA
occlusion by use of the salicylate hydroxylation method. They
positioned the microdialysis probe proximate to the penumbra which was
defined as having rCBF of 20 to 40% of control (Takagi et
al., 1993
; Back et al., 1995
). We positioned the
microdialysis probe more proximate to the motor area in which rCBF was
less than 44% of control. Thus, there is no apparent discrepancy of the ischemic insult in the penumbra between our model and
Morimoto's. Taking these findings and Morimoto's into consideration,
there seems to be no doubt that the oxygen radical species, including the hydroxyl radical, is increased in the penumbra of the permanent ischemic brain, where peroxidative attack by those toxic radical species may accelerate ischemic injury.
In focal ischemia, the participation of free radicals in the production
of ischemia or reperfusion injury was suggested by the effectiveness of
free radical scavenging drugs (Cao and Phillis, 1994
, Murota et
al., 1990
; Nishi et al., 1989
; Oh and Betz, 1991
) and
superoxide dismutase (Imaizumi et al., 1990
; Kinouchi
et al., 1991
). However, direct measurement of free radicals
in the ischemic penumbral cortex was only performed by use of the
salicylate hydroxylation method which could detect hydroxyl radicals
(Morimoto et al., 1996
; Ginsberg et al., 1994
).
In the present study, the OPB content was elevated in the ischemic
penumbral cortex after thrombotic dMCA occlusion, which suggests that
MCI-186 reacts with free radicals in vivo.
In conclusion, MCI-186 improved neurological deficits and reduced infarct area 1 day after occlusion when it was administered after thrombotic occlusion of the dMCA. In the penumbra, MCI-186 mainly changed into OPB. Our results may suggest that the reactive oxygen species contribute to brain injury after permanent focal ischemia and the treatment with MCI-186 in permanent focal ischemia would be beneficial.
| |
Acknowledgments |
|---|
The authors thank M. Nakashima and K. Umemura (Department Pharmacology, Hamamatsu University School of Medicine, Hamamatsu, Japan) for technical directions.
| |
Footnotes |
|---|
Accepted for publication December 23, 1996.
Received for publication September 4, 1996.
Send reprint requests to: Hiroshi Kawai, Ph.D., Pharmaceuticals Laboratory 2, Yokohama Research Center, Mitsubishi Chemical Corporation, 1000, Kamoshida-cho, Aoba-ku Yokohama 227, Japan.
| |
Abbreviations |
|---|
dMCA, distal middle cerebral artery; rCBF, regional cerebral blood flow; CCA, common carotid artery; IAP, iodoantipyrine; MCI-186, 3-methyl-1-phenyl-2-pyrazolin-5-one; OPB, 2-oxo-3-(phenylhydrazono)-butanoic acid; TBA, tetrabutylammonium chloride; HPLC, high-performance liquid chromatography; TTC, 1% 2,3,5-triphenyltetrazolium chloride.
| |
References |
|---|
|
|
|---|
-Phenyl-tert-butyl-nitrone reduces cortical infarct and edema in rats subjected to focal ischemia.
Brain Res.
644: 267-272, 1994[Medline].This article has been cited by other articles:
![]() |
K. Yagi, K. T. Kitazato, M. Uno, Y. Tada, T. Kinouchi, K. Shimada, and S. Nagahiro Edaravone, a Free Radical Scavenger, Inhibits MMP-9-Related Brain Hemorrhage in Rats Treated With Tissue Plasminogen Activator Stroke, February 1, 2009; 40(2): 626 - 631. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Suzuki, T. Kawamata, Y. Okada, T. Kobayashi, T. Nakamura, and T. Hori Filtrate of Phellinus linteus Broth Culture Reduces Infarct Size Significantly in a Rat Model of Permanent Focal Cerebral Ischemia Evid. Based Complement. Altern. Med., January 20, 2009; (2009) nen091v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tajima, M. Bando, Y. Ishii, T. Hosono, H. Yamasawa, S. Ohno, T. Takada, E. Suzuki, F. Gejyo, and Y. Sugiyama Effects of edaravone, a free-radical scavenger, on bleomycin-induced lung injury in mice Eur. Respir. J., November 1, 2008; 32(5): 1337 - 1343. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Arai, M. Nonogawa, K. Makino, N. Endo, H. Mori, T. Miyoshi, K. Yamashita, M. Sasada, M. Kakuyama, and K. Fukuda The Radical Scavenger Edaravone (3-Methyl-1-phenyl-2-pyrazolin-5-one) Reacts with a Pterin Derivative and Produces a Cytotoxic Substance That Induces Intracellular Reactive Oxygen Species Generation and Cell Death J. Pharmacol. Exp. Ther., February 1, 2008; 324(2): 529 - 538. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Koizumi, H. Tanaka, S. Sakaki, and S. Shimazaki The Therapeutic Efficacy of Edaravone in Extensively Burned Rats Arch Surg, October 1, 2006; 141(10): 992 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nimata, T.-a. Okabe, M. Hattori, Z. Yuan, K. Shioji, and C. Kishimoto MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats Am J Physiol Heart Circ Physiol, December 1, 2005; 289(6): H2514 - H2518. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Zhang, M. Komine-Kobayashi, R. Tanaka, M. Liu, Y. Mizuno, and T. Urabe Edaravone Reduces Early Accumulation of Oxidative Products and Sequential Inflammatory Responses After Transient Focal Ischemia in Mice Brain Stroke, October 1, 2005; 36(10): 2220 - 2225. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Nakajima, N. Kakui, K. Ohkuma, M. Ishikawa, and T. Hasegawa A Newly Synthesized Poly(ADP-Ribose) Polymerase Inhibitor, DR2313 [2-Methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: Pharmacological Profiles, Neuroprotective Effects, and Therapeutic Time Window in Cerebral Ischemia in Rats J. Pharmacol. Exp. Ther., February 1, 2005; 312(2): 472 - 481. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kono, M. Asakawa, H. Fujii, A. Maki, H. Amemiya, M. Yamamoto, M. Matsuda, and Y. Matsumoto Edaravone, a Novel Free Radical Scavenger, Prevents Liver Injury and Mortality in Rats Administered Endotoxin J. Pharmacol. Exp. Ther., October 1, 2003; 307(1): 74 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Toda and T. Okamura The Pharmacology of Nitric Oxide in the Peripheral Nervous System of Blood Vessels Pharmacol. Rev., June 1, 2003; 55(2): 271 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Satoh, N. Kashihara, S. Fujimoto, H. Horike, T. Tokura, T. Namikoshi, T. Sasaki, and H. Makino A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo J. Pharmacol. Exp. Ther., June 1, 2003; 305(3): 1183 - 1190. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||